It was shown that TMPRSS2 inhibition (by protease inhibitor or in TMPRSS2 knock-out mice) prevented viral entry and reduced the viral infection and severity of lung pathology with improved survival after SARS-CoV infection in mouse models [23,24]. This evidence concerns the gene TMPRSS2 and viral infectious disease.